GTBP GT BIOPHARMA INC Delisting Actions 8-K Filing 2023 - Delisting GT Biopharma received a deficiency letter from Nasdaq stating that their stock price has been below the minimum requirement for continued listing, but they have been given 180 days to regain compliance.Get access to all SEC 8-K filings of the GT BIOPHARMA INC